Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model
暂无分享,去创建一个
H. Hartung | P. Albrecht | D. Fischer | O. Aktas | A. Heskamp | C. Berndt | P. Küry | Zippora Kohne | Michael Dietrich | Andrea Issberner | A. Hilla | Thomas Hildebrandt | Niklas Helling
[1] R. Spain,et al. Lipoic acid in secondary progressive MS , 2017, Neurology: Neuroimmunology & Neuroinflammation.
[2] O. Firuzi,et al. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope? , 2017, Current drug targets.
[3] J. Wren,et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis , 2016, Molecular vision.
[4] Andrés Cruz-Herranz,et al. Whole-body positional manipulators for ocular imaging of anaesthetised mice and rats: a do-it-yourself guide , 2016, BMJ Open Ophthalmology.
[5] L. Wheless,et al. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis , 2016, Journal of neurochemistry.
[6] H. Hartung,et al. Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases , 2016, Front. Cell Dev. Biol..
[7] Pablo Villoslada,et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.
[8] H. Hartung,et al. Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. , 2016, Current opinion in neurology.
[9] Bernhard Hemmer,et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination , 2016, Multiple sclerosis.
[10] David H. Miller,et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial , 2016, The Lancet Neurology.
[11] K. Terao,et al. Enantioselective Pharmacokinetics of α-Lipoic Acid in Rats , 2015, International journal of molecular sciences.
[12] Suvankar Pal,et al. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography , 2015, Alzheimer's & dementia.
[13] R. Hermann,et al. Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms , 2014, Clinical pharmacology : advances and applications.
[14] K. Xie,et al. Oxidative Stress Induced by Lipid Peroxidation Is Related with Inflammation of Demyelination and Neurodegeneration in Multiple Sclerosis , 2014, European Neurology.
[15] M. Buttmann,et al. Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography , 2014, Acta neuropathologica communications.
[16] S. Eghtesadi,et al. Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial , 2014, Neuroimmunomodulation.
[17] Michel Paques,et al. Spectral-Domain Optical Coherence Tomography of the Rodent Eye: Highlighting Layers of the Outer Retina Using Signal Averaging and Comparison with Histology , 2014, PloS one.
[18] S. Eghtesadi,et al. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial , 2014, Nutritional neuroscience.
[19] H. Sytwu,et al. α-Lipoic acid enhances endogenous peroxisome-proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis in mice. , 2013, Clinical science.
[20] S. Matsugo,et al. Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline , 2013, Brain Research.
[21] Gerd Geerling,et al. Retinal Neurodegeneration in Wilson’s Disease Revealed by Spectral Domain Optical Coherence Tomography , 2012, PloS one.
[22] H. Bi,et al. Neuroprotective effect of alpha-lipoic acid on hydrostatic pressure-induced damage of retinal ganglion cells in vitro , 2012, Neuroscience Letters.
[23] H. Hartung,et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation , 2012, Journal of Neuroinflammation.
[24] A. Schnitzler,et al. Optical Coherence Tomography in Parkinsonian Syndromes , 2012, PloS one.
[25] P. Albrecht,et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography , 2012, Multiple sclerosis.
[26] Shiv Saidha,et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. , 2012, Brain : a journal of neurology.
[27] Ivana Gadjanski,et al. An optical coherence tomography study on degeneration of retinal nerve fiber layer in rats with autoimmune optic neuritis. , 2012, Investigative ophthalmology & visual science.
[28] D. Bourdette,et al. Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis , 2011, Journal of Neuroimmunology.
[29] Mary T. Brinkoetter,et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Nature Medicine.
[30] H. D. de Vries,et al. Radical changes in multiple sclerosis pathogenesis. , 2011, Biochimica et biophysica acta.
[31] N. Scolding,et al. Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment , 2010, Autoimmune diseases.
[32] Y. Bayir,et al. α-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations , 2010, British Journal of Nutrition.
[33] D. Bourdette,et al. Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters , 2010, Multiple sclerosis.
[34] Andreas Wenzel,et al. Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography , 2009, PloS one.
[35] D. Bourdette,et al. Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells , 2008, Journal of Neuroimmunology.
[36] B. Oken,et al. Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning , 2008, Brain, behavior, and immunity.
[37] Jean Bennett,et al. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis , 2006, Multiple sclerosis.
[38] R. Musters,et al. Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity1 , 2006, The Journal of Immunology.
[39] R. Douglas,et al. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. , 2004, Investigative ophthalmology & visual science.
[40] Daniel Offen,et al. The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy , 2004, Journal of Neurology.
[41] L. Roccatagliata,et al. α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.
[42] D. Bourdette,et al. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.
[43] J. Flier,et al. The Neuroprotective Antioxidant α-lipoic Acid Induces Detoxication Enzymes in Cultured Astroglial Cells , 2002, Free radical research.
[44] E. Lavi,et al. Cutting Edge: C3, a Key Component of Complement Activation, Is Not Required for the Development of Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis in Mice1 , 2001, The Journal of Immunology.
[45] R. Douglas,et al. Behavioral assessment of visual acuity in mice and rats , 2000, Vision Research.
[46] D. Roos,et al. Reactive oxygen species are required for the phagocytosis of myelin by macrophages , 1998, Journal of Neuroimmunology.
[47] R. Hermann,et al. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers , 1996 .
[48] A. Bast,et al. Reduction of lipoic acid by lipoamide dehydrogenase. , 1996, Biochemical pharmacology.
[49] L. Packer,et al. alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.
[50] Christine D. Dijkstra,et al. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.
[51] Dean P. Jones,et al. Oxidative Stress. , 2017, Annual review of biochemistry.
[52] Bernhard Hemmer,et al. Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis. , 2015, Journal of autoimmunity.
[53] 松永 芳径. Visual functional and histopathological correlation in experimental autoimmune optic neuritis , 2013 .
[54] G. Münch,et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. , 2007, Pharmacology & therapeutics.
[55] L. Roccatagliata,et al. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. , 2004, Journal of neuroimmunology.
[56] J. Flier,et al. The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. , 2002, Free radical research.
[57] S. Grieb,et al. Enantioselective high-performance liquid chromatography assay of (+)R- and (-)S-alpha-lipoic acid in human plasma. , 1997, Chirality.
[58] U. Gundert-Remy,et al. Influence of food intake on the bioavailability of thioctic acid enantiomers , 1996, European Journal of Clinical Pharmacology.
[59] B. Golding,et al. Proof that the absolute configuration of natural α-lipoic acid is R by the synthesis of its enantiomer [(S)-(–)-α-lipoic acid] from (S)-malic acid , 1983 .